SCHEMBL7257293

SCHEMBL7257293

O=S(=O)(NS(=O)(=O)OCC(F)(F)F)OCC(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24385364 0.87 CA1 (0.50) CA1CA2CA9
SCHEMBL775983 0.79 CA1 (0.65) CA1CA2CA9HTT
SCHEMBL7257310 0.79 CA1 (0.36) CA1CA2CA9
SCHEMBL9632143 0.79 CA1 (0.52) CA1CA2CA9HTT
SCHEMBL26367020 0.75 CA1 (0.48) CA1CA2CA9
SCHEMBL7257180 0.75 ALDH1A1 (0.35) CA1CA2CA9
SCHEMBL25169212 0.75 CA1 (0.48) CA1CA2CA9
SCHEMBL10679540 0.74 CA1 (0.59) CA1CA2CA9HTT
SCHEMBL21918062 0.74 CA1 (0.46) CA1CA2CA9
SCHEMBL796831 0.72 CA1 (0.56) CA1CA2CA9HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240093395-A1 ELECTROLYSIS DEVICE AND ELECTROLYSIS METHOD KABUSHIKI KAISHA TOSHIBA (JP) 2024-03-21 US disclosed
EP-4339336-A2 ELECTROLYSIS DEVICE AND ELECTROLYSIS METHOD KABUSHIKI KAISHA TOSHIBA (JP) 2024-03-20 EP disclosed
US-6642404-B2 Reacting a bis(chlorosulfonyl)amine with a fluoroalcohol CENTRAL GLASS COMPANY, LIMITED (JP) 2003-11-04 US disclosed
US-20010012903-A1 Amines or salts thereof and methods of preparing same CENTRAL GLASS COMPANY, LIMITED 2001-08-09 US disclosed
US-6235921-B1 REACTION BIS/CHLOROSULFONYL/AMINE AND FLUORO ALCOHOL CENTRAL GLASS COMPANY, LIMITED (JP) 2001-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010012903-A1 Amines or salts thereof and methods of preparing same NSUN2, RTF1, NHERF1 CA1 794/4885CA2 454/4885CA9 1722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.